한글목차

세계 MCD(다중 암 진단) 검사 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별·지역별 상세 분석, 신기술 동향, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 요약과 하이라이트

• 시장 전망
• 시장 요약

제3장 시장 및 기술 배경

• 바이오마커 종류
• 향후 전망

제4장 시장 역학

• 시장 역학 현황
• 시장 성장 촉진요인
• 암 검진의 미충족 수요
• 암 검진에 대한 정부 이니셔티브
• 시장 성장 억제요인
• 위양성 또는 위음성 리스크
• 규제와 상환 불확실성

제5장 시장 내역 : 테스트 유형별

• 세계의 MCD(다중 암 진단) 검사 시장 : 검사 유형별
• 시장 규모와 예측
• 실험실 개발 검사
• 체외진단 검사

제6장 시장 내역 : 최종사용자별

• 세계의 MCD(다중 암 진단) 검사 시장 : 최종사용자별
• 병원
• 진단 실험실
• 연구기관

제7장 시장 내역 : 지역별

• 세계의 MCD(다중 암 진단) 검사 시장 : 지역별
• 미국
• 유럽
• 신흥 시장

제8장 신기술

• 기원 조직 특정
• 프래그멘토믹스 및 종양 유발 혈소판
• 이미지 데이터 분석을 수반하는 액체 생검

제9장 경쟁 상황

• Porter's Five Forces 분석
• 최근의 동향
• 임상시험 활동

제10장 기업 개요

• ANCHORDX MEDICAL CO. LTD.
• BURNING ROCK BIOTECH LTD.
• DELFI DIAGNOSTICS
• EXACT SCIENCES CORP.
• FREENOME HOLDINGS INC.
• GENECAST INC.
• GRAIL INC.
• GUARDANT HEALTH INC.

영문목차

Highlights:

This report provides an in-depth analysis of the global multi-cancer diagnostic (MCD) test market. It highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products.

Report Scope:

The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections for 2028. The report details the market share of MCD tests based on type and end user. The market is segmented into laboratory-developed tests and in-vitro diagnostic tests based on test type. The market is segmented into diagnostic laboratories, hospitals and research institutions based on end user. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products. The study does not include single cancer early detection tests and detection tests for targeted therapies.

The regional markets covered are U.S., Europe and emerging markets.

Revenues are broken down by region, type and end user. For market estimates, data has been provided for 2020 and 2021 as historic years, 2022 as the base year, 2023 and a forecast for 2028.

Report Includes:

• An overview of the global market for the multi-cancer diagnostic tests
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Highlights of the current and future market potential of multi-cancer detection tests along with a detailed analysis of the drivers and challenges in the market
• Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by test type, end-user, and region
• Overview of the significant driving trends and challenges that affect the global market and its vendor landscape
• Discussion of sustainability trends and ESG developments in the multi-cancer diagnostic tests market, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices followed
• Information pertaining to the recent developments and upcoming technologies in the market
• An analysis of the market competitive landscape featuring the company revenue share analyses, recent mergers and acquisition activities, and venture funding outlook
• Company profiles of the major global players

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of the Report
• Methodology
• Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market and Technology Background

• Introduction
• Types of Biomarkers
• Future Outlook

Chapter 4 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Unmet Needs in Cancer Screening
• Government Measures for Cancer Screening
• Market Restraints
• Risk of False Positives or False Negatives
• Regulatory and Reimbursement Uncertainty

Chapter 5 Market Breakdown by Test Type

• Global Multi-Cancer Diagnostic Test Market, by Test Type
• Market Size and Forecast
• Laboratory Developed Tests
• In-Vitro Diagnostic Tests

Chapter 6 Market Breakdown by End User

• Global Multi-Cancer Diagnostic Test Market, by End User
• Hospitals
• Diagnostic Laboratories
• Research Institutions

Chapter 7 Market Breakdown by Region

• Global Multi-Cancer Diagnostic Test Market, by Region
• The U.S.
• Europe
• Emerging Markets

Chapter 8 Emerging Technologies

• Introduction
• Identification of Tissue of Origin
• Fragmentomics and Tumor-Educated Platelets
• Liquid Biopsy with Imaging Data Analysis

Chapter 9 Competitive Landscape

• Porter's Five Forces Analysis
• Threat of New Entrants
• Threat of Substitutes
• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Degree of Competition
• Recent Developments in the Multi-Cancer Diagnostic Market
• Clinical Trial Activities

Chapter 10 Company Profiles

• ANCHORDX MEDICAL CO. LTD.
• BURNING ROCK BIOTECH LTD.
• DELFI DIAGNOSTICS
• EXACT SCIENCES CORP.
• FREENOME HOLDINGS INC.
• GENECAST INC.
• GRAIL INC.
• GUARDANT HEALTH INC.